References
- Lathan CS, Cronin A, Tucker-Seeley R, et al Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016;34(15):1732–1740.
- Gordon LG, Merollini KM, Lowe A, et al A systematic review of financial toxicity among cancer survivors: We can't pay the co-pay. Patient. 2017;10(3):295–309.
- Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821–2826.
- Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608–1614.
- de Souza JA, Yap BJ, Wroblewski K, Blinder V, et al Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the Comprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476–484.
- Davis TC, Williams MV, Marin E, et al Health literacy and cancer communication. CA Cancer J Clin. 2002;52(3):134–49.
- Jagsi R, Pottow JA, Griffith KA, Bradley C, et al Long-term financial burden of breast cancer: Experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014; 20;32(12):1269–76.
- Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors' financial burden and quality of life: A prospective cohort study. J Oncol Pract. 2015;11(2):145–150.
- Delgado-Guay M, Ferrer J, Rieber AG, Rhondali W, et al Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist. 2015;20(9):1092–1098.